[Clinical studies with a new vasoactive polypeptide POR-8 (ornithine-8-vasopressin). Effect on intermediary carbohydrate metabolism (lactate, pyruvate, lactate-excess)].
D000328:Adult; D000758:Anesthesia; D001775:Blood Circulation / Q000187:drug effects; D003864:Depression, Chemical; D004344:Drug Incompatibility; D004562:Electrocardiography; D005260:Female; D006221:Halothane; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007773:Lactates / Q000097:blood*; D008297:Male; D009952:Ornithine / Q000494:pharmacology*; D011773:Pyruvates / Q000097:blood*; D013268:Stimulation, Chemical; D014667:Vasopressins / Q000494:pharmacology*
D007773:Lactates; D011773:Pyruvates; D014667:Vasopressins; D009952:Ornithine; D006221:Halothane
Klinische Untersuchung mit einem vasoaktiven Polypeptid POR-8 (Ornithin-8-Vasopressin)